CUSIP: 71714G102
Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
25,283,374
-
Share change
-
+3,223,801
-
Total reported value
-
$61,688,535
-
Put/Call ratio
-
72%
-
Price per share
-
$2.44
-
Number of holders
-
47
-
Value change
-
+$8,865,566
-
Number of buys
-
36
-
Number of sells
-
10
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2016
-
Previous quarter:
Q1 2016
Recent filing periods for CUSIP 71714G102:
Institutional Holders of PHARMATHENE INC - COM (PIP) as of Q2 2016
As of 30 Jun 2016,
PHARMATHENE INC - COM (PIP) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,283,374 shares.
The largest 10 holders included
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C., Nantahala Capital Management, LLC, Hudson Bay Capital Management LP, VANGUARD GROUP INC, BlackRock Fund Advisors, ONTARIO TEACHERS PENSION PLAN BOARD, PERKINS CAPITAL MANAGEMENT INC, BRIDGEWAY CAPITAL MANAGEMENT INC, NORTHERN TRUST CORP, and STATE STREET CORP.
This page lists
47
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.